Brussels, 02/09/2009 (Agence Europe) - Addressing the European Parliament environment and public health committee on Tuesday 1 September, Commission Vice-President Günter Verheugen welcomed the considerable progress made in drug monitoring and tackling counterfeit medicines, two of the three points in the pharmaceutical package that is currently being debated. While hoping that a solid outcome can be reached quickly on these two issues, he did not hide his frustration on the draft directive...